跳至主要内容
临床试验/ACTRN12622001444774
ACTRN12622001444774已完成未知

Effect of potassium bicarbonate supplementation on myofibrillar protein synthesis in older women

Dr Caoileann Murphy0 个研究点目标入组 20 人开始时间: 2022年11月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
65 Years 至 90 Years(—)
性别
Female

入选标准

  • Women aged between 65 and 90 y
  • - 24-h urine pH of less than or equal to 6.7 at screening

排除标准

  • Self-reported history of conditions impacting acid-base balance (i.e. renal disease, addison’s disease, severe COPD with CO2 retention, kidney stones in last 2 years, liver cirrhosis), active hyperparathyroidism, untreated thyroid disease, significant immune disorders, unstable heart disease, primary aldosteronism, active malignancy, type 1 diabetes mellitus, active inflammatory bowel disease, neuromuscular disease (e.g. Myasthenia gravis, MS, muscular dystrophies, MND), Parkinson’s disease
  • Medications that can impact acid-base balance, skeletal muscle / bone turnover (i.e. current use of diuretics, antacids containing aluminum hydroxide or magnesium hydroxide), HRT, insulin, drugs affecting bone turnover (bisphosphonates or denosumab in the last year, other osteoporosis medications [Tamoxifen/raloxifene, calcitonin, oestrogen] in the last 3 months, glucocorticoids for >10 days in the last 3 months), simvastatin / zocor, oestrogen suppressants , warfarin, anticoagulants other than aspirin (will be stopped 3 days prior to each biopsy)
  • Glomerular filtration rate (GFR) <51 mL/min/1.73m2 and a serum potassium >5.3 mmol/L (assessed during participant screening)
  • Regular resistance structured training (> 1 sessions of structured training / week)
  • Participants taking nutritional supplements will be asked to cease taking these 2 weeks prior to, and for the duration of the study, including potassium-containing salt substitutes
  • Total walking incapacity
  • Women must be at least 1 year since last menses
  • Bone mineral density (BMD) T-score below -2.5 at the lumbar spine or total hip
  • Cachexia – defined as unintentional weight loss > 5% in last 6 months or, in persons with BMI < 20 kg/m2 weight loss > 2%, or low muscle mass (ASMI < 7 kg/m2 in men, < 5.5 kg/m2 in women) plus > 2% weight loss in individuals with an underlying condition associated with cachexia
  • Current infectious disease or diagnosis of bloodborne disease
  • Allergy to local anaesthesia
  • Mini Mental State Examination (MMSE) score < 24
  • If participant’s GP reports they have an excluded condition or are taking an excluded medication

研究者

发起方
Dr Caoileann Murphy

相似试验